FBInvestor
Stocks / 4d Molecular Therapeutics In
Institutional Ownership

4d Molecular Therapeutics In

CUSIP 35104E100COMFDMTQ1 2026

Analyst forecast

Analyst recommendation trends (Buy / Hold / Sell consensus) come from a market-data feed. This activates once the forecast feed is connected and this ticker is covered.

Coming soon